Patents by Inventor Juan Manuel FALCÓN PÉREZ

Juan Manuel FALCÓN PÉREZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11337966
    Abstract: The present invention relates to the use of the compound ciclopirox or a pharmaceutically acceptable salt or solvate thereof for the treatment and/or prevention of a disease caused by dysregulated heme group biosynthesis, with the proviso that said disease is not congenital erythropoietic porphyria.
    Type: Grant
    Filed: April 27, 2018
    Date of Patent: May 24, 2022
    Assignee: ASOCIACIÓN CENTRO DE INVESTIGACIÓN COOPERATIVA EN BIOCIENCIAS-CIC BIOGUNE
    Inventors: Oscar Millet Aguilar-Galindo, Arantza Sanz Parra, Ana Laín Torre, Pedro David Urquiza Ortiz, Juan Manuel Falcón Pérez, Joaquín Castilla Castrillón, Itxaso San Juan Quintana, Ganeko Bernardo-Seisdedos
  • Publication number: 20200171013
    Abstract: The present invention relates to the use of the compound ciclopirox or a pharmaceutically acceptable salt or solvate thereof for the treatment and/or prevention of a disease caused by dysregulated heme group biosynthesis, with the proviso that said disease is not congenital erythropoietic porphyria.
    Type: Application
    Filed: April 27, 2018
    Publication date: June 4, 2020
    Inventors: Oscar MILLET AGUILAR-GALINDO, Arantza SANZ PARRA, Ana LAÍN TORRE, Pedro David URQUIZA ORTIZ, Juan Manuel FALCÓN PÉREZ, Joaquín CASTILLA CASTRILLÓN, Itxaso SAN JUAN QUINTANA, Ganeko BERNARDO-SEISDEDOS
  • Publication number: 20200173997
    Abstract: The present invention relates to biomarkers for colorectal cancer. Specifically, it relates to metabolic markers as a screening, diagnostic or monitoring tool for detecting colorectal cancer (CRC) and/or advanced adenoma (AD) in a subject. In a particular embodiment, it refers to an in vitro method for the screening, diagnosis or monitoring of colorectal cancer and/or advanced adenoma in a subject, said method comprising the following steps: a) determining the levels of the metabolic marker ChoE(18:2) in a feces sample isolated from said subject; b) comparing the levels in said feces sample with a reference value; wherein an increase of ChoE(18:2) levels in the subject sample with regard to said reference value is indicative of CRC and/or AD.
    Type: Application
    Filed: May 11, 2018
    Publication date: June 4, 2020
    Inventors: Joaquín CUBIELLA FERNÁNDEZ, Juan Manuel FALCÓN PÉREZ, Luis BUJANDA FERNÁNDEZ DE PIEROLA
  • Patent number: 10420755
    Abstract: The present invention relates to the use of the compound ciclopirox or a pharmaceutically acceptable salt or solvate thereof for the treatment and/or prevention of congenital erythropoietic porphyria (CEP).
    Type: Grant
    Filed: October 27, 2017
    Date of Patent: September 24, 2019
    Assignee: ASOCIACIÓN CENTRO DE INVESTIGACIÓN COOPERATIVA EN BIOCIENCIAS-CIC BIOGUNE
    Inventors: Oscar Millet Aguilar-Galindo, Arantza Sanz Parra, Ana Laín Torre, Pedro David Urquiza Ortiz, Juan Manuel Falcón Pérez
  • Publication number: 20190183871
    Abstract: The present invention relates to the use of the compound ciclopirox or a pharmaceutically acceptable salt or solvate thereof for the treatment and/or prevention of congenital erythropoietic porphyria (CEP).
    Type: Application
    Filed: October 27, 2017
    Publication date: June 20, 2019
    Inventors: Oscar MILLET AGUILAR-GALINDO, Arantza SANZ PARRA, Ana LAÍN TORRE, Pedro David URQUIZA ORTIZ, Juan Manuel FALCÓN PÉREZ